Study of DCC-2618 in Patients With GIST After at Least 3 Prior Treatments
Abroad (travel likely)RecruitingPHASE1
Conditions
Gastrointestinal Stromal Tumors
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Cancer Center Hospital East, Kashiwa, Chiba, Japan
National Cancer Center Hospital, Tokyo, Chuo-ku, Japan
Study leads
Project Leader
Study Director
Ono Pharmaceutical Co., Ltd.